Recent advances in nanotherapeutic strategies that target nitric oxide pathway for preventing cartilage degeneration

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Rheumatology

Background:

• Nitric oxide (NO) is a key inflammatory mediator in osteoarthritis (OA) pathogenesis.
• Elevated NO levels in joints contribute to cartilage degradation.
• Inducible NO synthase (iNOS) catalyzes NO synthesis, making it a therapeutic target.

Purpose of the Study:

• To review limitations of current NO-targeting molecules for OA.
• To explore nanotechnology-based strategies for OA diagnosis and NO inhibition.
• To assess the potential of NO-targeting approaches in OA management.

Main Methods:

• Discussion of existing iNOS inhibitors and their clinical drawbacks.
• Review of recent nanotechnology applications for NO modulation in OA.
• Analysis of diagnostic and therapeutic nanotechnology-based strategies.

Main Results:

• Existing iNOS inhibitors face challenges with bioavailability and side effects, hindering clinical application.
• Nanotechnology-based strategies show promise for targeted NO inhibition and OA diagnosis.
• These novel approaches may overcome limitations of conventional therapies.

Conclusions:

• Targeting NO remains a promising strategy for OA treatment.
• Nanotechnology provides innovative solutions to enhance NO inhibition and diagnosis in OA.
• Further development of nanotechnology-based NO-targeting agents is warranted for OA therapeutics.